• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Mirena
    / Bayer


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Intrauterine Device

    1

    partial basket chart 26390 13732

    Dosage

    See prescribing information for full details.


    Indications

    Contraception, idiopathic menorrhea, protection from endometrial hyperplasia during estrogen replacement therapy.


    Contra-Indications

    Known or suspected pregnancy, genital infection, suspected or confirmed uterine/cervical malignant, undiagnosed abnormal uterine bleeding, congenital/ acquired uterine anomality including fibroids, acute liver disease, liver tumor, venous thrombo-embolism, acute/recurring pelvic inflammatory disease, previous bacterial endocarditis, severe pelvic infection with anomalic. cardiac lesion, prosthetic valve replacement, arterial disease, immunodeficiency, acute malignancy affecting blood, leukemia except when in remission, recent trophoblastic disease while HCG levels elevated.
    See prescribing information for full details.


    Special Precautions

    See prescribing information for full details.


    Side Effects

    Menstrual changes, lower abdominal pain, acne/skin problems.
    See prescribing information for full details.


    Drug interactions

    Rifampicin, griseofulvin, barbiturates, phenytoin, primidone, carbamazepine. See prescribing information for full details.


    Manufacturer
    Bayer Schering Pharma Oy
    Licence holder
    CLOSE